Piscataqua Savings Bank’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
LMFP
SI
CPC
GGI
FWCM
QCM
DADC
MIM
DLA
Piscataqua Savings Bank's NVS Position: Q2 2026 in Review
Piscataqua Savings Bank reduced its Novartis (NVS) stake by 24% in Q2 2026, selling an estimated $52.5K and leaving 1,079 shares worth $169K. The position accounts for 0.11% of the portfolio, ranked #115.
Piscataqua Savings Bank first reported a position in NVS in Q1 2021 and has held it in 22 quarters since. The position peaked at $218K in Q1 2026. 509 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Piscataqua Savings Bank held 1,079 shares of Novartis worth $169K as of Q2 2026.
- Piscataqua Savings Bank sold 350 Novartis shares in Q2 2026, an estimated $52.5K.
- Novartis made up 0.11% of Piscataqua Savings Bank's portfolio in Q2 2026, its #115 holding.
- Piscataqua Savings Bank first reported a position in Novartis in Q1 2021 and has held it in 22 quarters since.
- Piscataqua Savings Bank's Novartis position peaked at $218K in Q1 2026.
- 509 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Piscataqua Savings Bank's 13F filing for Q2 2026, filed 9 Jul 2026.